In the release, Dean Li, president of Merck Research Laboratories, said the oral drug has "potential to provide additional cardiometabolic benefits beyond weight reduction." Merck CEO Rob Davis early last year said the company was seeking GLP-1 treatments with benefits beyond weight loss

First, antioxidant properties allow alpha-lipoic acid to neutralize free radicals and reduce oxidative stress, which is linked to damage that can increase heart disease risk ( Second, its been shown to improve endothelial dysfunction a condition in which blood vessels cannot dilate properly, which also raises the risks of heart attack and stroke ( Whats more, a review of studies found that taking an alpha-lipoic acid supplement lowered triglyceride and LDL (bad) cholesterol levels in adults with metabolic disease ( Summary Alpha-lipoic acid has strong antioxidant properties, which may reduce inflammation and skin aging, promote healthy nerve function, lower heart disease risk factors, and slow the progression of memory loss disorders
The semaglutide and the combination-therapy group had semaglutide treatment for 16 weeks and then had either tablet placebo or empagliflozin added to the treatment, respectively, for a further 16 weeks
Actually, I should mention something about the injection sites
This 28-day window applies whether you use the pen once weekly or follow a customized dosing schedule